Cargando…
Comparison of the different mechanisms of cytotoxicity induced by Checkpoint Kinase I inhibitors when used as single agents or in combination with DNA damage
Inhibition of the DNA damage response is an emerging strategy to treat cancer. Understanding how DNA damage response inhibitors cause cytotoxicity in cancer cells is crucial to their further clinical development. This review focuses on three different mechanisms of cell killing by Checkpoint Kinase...
Autores principales: | Warren, Nicholas J.H., Eastman, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023985/ https://www.ncbi.nlm.nih.gov/pubmed/31659257 http://dx.doi.org/10.1038/s41388-019-1079-9 |
Ejemplares similares
-
Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013) -
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
por: Boonsri, Boonyakorn, et al.
Publicado: (2021) -
When heat casts a spell on the DNA damage checkpoints
por: Turner, Thomas, et al.
Publicado: (2014) -
Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors
por: Sokhi, Sargun, et al.
Publicado: (2023) -
Working hard for recovery: mitotic kinases in the DNA damage checkpoint
por: Peng, Aimin
Publicado: (2013)